NCT03894423Active, not recruiting
Comprehensive Computed Tomography Guidance of Coronary Bypass Graft Surgery
Comprehensive CT Guided Coronary Bypass Graft Surgery
Source: ClinicalTrials.gov · Last updated 17 Apr 2026
Brief summary (registry, in English)
Apply CT angiography, CT perfusion imaging and advanced image processing techniques to improve revascularization decision-making and surgical strategies in patients undergoing coronary artery bypass graft surgery.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 22 Mar 2019
- Start date
- 1 May 2019
- Primary completion date
- Dec 2026
- Lead sponsor
- Stanford University
- Diseases
- Coronary artery disease
- NCT number
- NCT03894423
What you commit to
- Study type: Observational
- Planned participants: 200
- From 1 May 2019 to the primary completion date, Dec 2026
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Overall safety: unstable clinical condition (clinical heart failure, unstable angina, myocardial infarction \<1 month prior).
- Radiation risk: pregnancy (cannot be ruled out), body weight \>100kg.
Other illness
- Technical feasibility of the cardiac CT exams: redo-CABG, significant arrhythmia/mal-conduction, congenital conditions, severe valvular disease or cardiomyopathy (to the extent that the CT acquisition is technically challenged), inadequate understanding of the English language (to provide consent or follow instructions during the exams).
- CT contrast medium-related: known allergy, renal failure
- Vasodilator related: known allergy, bronchial asthma requiring daily use of bronchodilators, Mobitz II or 3rd degree AV block, sick sinus node disease, clinically significant carotid artery narrowing, severe aortic stenosis or LVOT narrowing, systolic blood pressure below 90mmHg, (continued) use of dipyridamole or aminophylline.
Other
- Inability to provide informed consent.
Who the study is looking for
- Planned elective CABG for coronary artery disease.
- CABG is the primary indication for surgery (but may include treatment of mild-moderate valvular disease).
- Age: ≥40 years.
Age in the registry: 40 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Stanford University Coordinator of this site? Confirm its status | Palo Alto | United States | Unknown status |
| Palo Alto Veterans Affaird Healthcare System Coordinator of this site? Confirm its status | Palo Alto | United States | Unknown status |
| University of California San Diego Coordinator of this site? Confirm its status | San Diego | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.